FOXM1 and cancer: There is clearly a great need to define combination treatments most effective against the drug-resistant cancer cell state, and we have found that promoting ferroptosis by using activators of ferroptosis may be a good way to treat cancer and enhance therapeutic response to FOXM1 inhibition.